These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 3753020

  • 1. [Treatment of breast cancer based on its specific biological behavior].
    Tominaga T.
    Gan To Kagaku Ryoho; 1986 Sep; 13(9):2718-25. PubMed ID: 3753020
    [Abstract] [Full Text] [Related]

  • 2. Outcome prediction for estrogen receptor-positive breast cancer based on postneoadjuvant endocrine therapy tumor characteristics.
    Ellis MJ, Tao Y, Luo J, A'Hern R, Evans DB, Bhatnagar AS, Chaudri Ross HA, von Kameke A, Miller WR, Smith I, Eiermann W, Dowsett M.
    J Natl Cancer Inst; 2008 Oct 01; 100(19):1380-8. PubMed ID: 18812550
    [Abstract] [Full Text] [Related]

  • 3. [A case of advanced breast cancer with multiple organ metastases successfully treated by tamoxifen].
    Shiba E, Kobayashi T, Takeda T, Miya A, Kawano I, Takai S, Mori T.
    Gan To Kagaku Ryoho; 1992 Nov 01; 19(13):2255-8. PubMed ID: 1444494
    [Abstract] [Full Text] [Related]

  • 4. Expression of bcl-2 protein predicts efficacy of adjuvant treatments in operable node-positive breast cancer.
    Gasparini G, Barbareschi M, Doglioni C, Palma PD, Mauri FA, Boracchi P, Bevilacqua P, Caffo O, Morelli L, Verderio P.
    Clin Cancer Res; 1995 Feb 01; 1(2):189-98. PubMed ID: 9815973
    [Abstract] [Full Text] [Related]

  • 5. Chemoendocrine compared with endocrine adjuvant therapies for node-negative breast cancer: predictive value of centrally reviewed expression of estrogen and progesterone receptors--International Breast Cancer Study Group.
    Viale G, Regan MM, Maiorano E, Mastropasqua MG, Golouh R, Perin T, Brown RW, Kovács A, Pillay K, Ohlschlegel C, Braye S, Grigolato P, Rusca T, Gelber RD, Castiglione-Gertsch M, Price KN, Goldhirsch A, Gusterson BA, Coates AS.
    J Clin Oncol; 2008 Mar 20; 26(9):1404-10. PubMed ID: 18349391
    [Abstract] [Full Text] [Related]

  • 6. [Histochemical and biochemical assays of estrogen receptors in breast cancer and significance of endocrine therapy].
    Tominaga T.
    Gan No Rinsho; 1983 May 20; 29(6):628-31. PubMed ID: 6308307
    [Abstract] [Full Text] [Related]

  • 7. Expression of the calcium receptor in human breast cancer--a potential new marker predicting the risk of bone metastases.
    Mihai R, Stevens J, McKinney C, Ibrahim NB.
    Eur J Surg Oncol; 2006 Jun 20; 32(5):511-5. PubMed ID: 16564154
    [Abstract] [Full Text] [Related]

  • 8. [The importance of steroid receptors for the prognosis and hormone treatment of breast cancer patients: a retrospective study in Southeastern Netherlands].
    Voogd AC, Crommelin MA, Repelaer van Driel OJ, Tutein Nolthenius-Puylaert MC, Vreugdenhil G, Coebergh JW.
    Ned Tijdschr Geneeskd; 1998 Aug 01; 142(31):1772-8. PubMed ID: 9856143
    [Abstract] [Full Text] [Related]

  • 9. [Statistical studies on metastasis of breast cancer and cancer metastasis to the breast].
    Urano Y, Fukushima T, Kitamura S, Mori H, Baba K, Aizawa S.
    Gan No Rinsho; 1986 Jan 01; Suppl():205-23. PubMed ID: 3959329
    [Abstract] [Full Text] [Related]

  • 10. Current and future status of adjuvant therapy for breast cancer.
    Coleman RE.
    Cancer; 2003 Feb 01; 97(3 Suppl):880-6. PubMed ID: 12548590
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Feasibility and therapeutic efficacy of weekly 1-h low-dose paclitaxel infusion for relapsed breast cancer.
    Kim R, Osaki A, Toge T.
    Oncol Rep; 2003 Feb 01; 10(1):145-50. PubMed ID: 12469161
    [Abstract] [Full Text] [Related]

  • 13. Comparison of anastrozole versus tamoxifen as preoperative therapy in postmenopausal women with hormone receptor-positive breast cancer: the Pre-Operative "Arimidex" Compared to Tamoxifen (PROACT) trial.
    Cataliotti L, Buzdar AU, Noguchi S, Bines J, Takatsuka Y, Petrakova K, Dube P, de Oliveira CT.
    Cancer; 2006 May 15; 106(10):2095-103. PubMed ID: 16598749
    [Abstract] [Full Text] [Related]

  • 14. Expression of prostate-specific antigen (PSA) correlates with poor response to tamoxifen therapy in recurrent breast cancer.
    Foekens JA, Diamandis EP, Yu H, Look MP, Meijer-van Gelder ME, van Putten WL, Klijn JG.
    Br J Cancer; 1999 Feb 15; 79(5-6):888-94. PubMed ID: 10070886
    [Abstract] [Full Text] [Related]

  • 15. Overexpression of cyclin D1 messenger RNA predicts for poor prognosis in estrogen receptor-positive breast cancer.
    Kenny FS, Hui R, Musgrove EA, Gee JM, Blamey RW, Nicholson RI, Sutherland RL, Robertson JF.
    Clin Cancer Res; 1999 Aug 15; 5(8):2069-76. PubMed ID: 10473088
    [Abstract] [Full Text] [Related]

  • 16. The nature of tamoxifen action in the control of female breast cancer.
    Kodama M, Kodama T.
    In Vivo; 2001 Aug 15; 15(4):319-25. PubMed ID: 11695224
    [Abstract] [Full Text] [Related]

  • 17. Risk of early recurrence among postmenopausal women with estrogen receptor-positive early breast cancer treated with adjuvant tamoxifen.
    Kennecke H, McArthur H, Olivotto IA, Speers C, Bajdik C, Chia SK, Ellard S, Norris B, Hayes M, Barnett J, Gelmon KA.
    Cancer; 2008 Apr 01; 112(7):1437-44. PubMed ID: 18286526
    [Abstract] [Full Text] [Related]

  • 18. Adjuvant chemotherapy of early breast cancer.
    Med Lett Drugs Ther; 1990 May 18; 32(818):49-50. PubMed ID: 2333039
    [No Abstract] [Full Text] [Related]

  • 19. Content of epidermal growth factor receptor in metastatic breast cancer: its role in endocrine sensitivity prediction.
    Nesković-Konstantinović ZB, Nikolić-Vukosavljević DB, Branković-Magić MV, Mitrovic LB, Spuzić I.
    Neoplasma; 2000 May 18; 47(2):107-13. PubMed ID: 10985476
    [Abstract] [Full Text] [Related]

  • 20. Tumor-specific expression of vascular endothelial growth factor receptor 2 but not vascular endothelial growth factor or human epidermal growth factor receptor 2 is associated with impaired response to adjuvant tamoxifen in premenopausal breast cancer.
    Rydén L, Jirström K, Bendahl PO, Fernö M, Nordenskjöld B, Stål O, Thorstenson S, Jönsson PE, Landberg G.
    J Clin Oncol; 2005 Jul 20; 23(21):4695-704. PubMed ID: 16034044
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.